Malignant tumours of the parotid: a study of 76 patients.

Clin Otolaryngol Allied Sci

Département de Carcinologie Cervico-Faciale, Institut Gustave-Roussy, Villejuif, France.

Published: April 1990

AI Article Synopsis

  • The study analyzes malignant parotid tumors treated at the Institut Gustave-Roussy from 1975 to 1984, highlighting the diverse histological types present.
  • Management primarily relies on histology, with effective treatment involving total parotidectomy while aiming to preserve the facial nerve, followed by routine radiotherapy to reduce local recurrence.
  • The 5-year survival rates for common tumor types are 49% for adenocarcinoma, 83% for adenoid cystic carcinoma, and 75% for mucoepidermoid carcinoma, with inoperable cases primarily receiving radiotherapy since chemotherapy has been ineffective.

Article Abstract

This study presents a series of malignant parotid tumours treated at the Institut Gustave-Roussy between 1975 and 1984. The lesions represented a wide variety of histological types. Few preoperative investigations were required, management being based on histology. Effective local control requires a total parotidectomy preserving the facial nerve where possible. It should be followed by routine radiotherapy which appears to reduce the incidence of local recurrence. The rate of local recurrence also depends on the histological type. It is seen more frequently in an adenocarcinoma following a pleomorphic adenoma than in simple adenocarcinoma. Patients with inoperable disease are treated with radiotherapy alone as chemotherapy has not so far been effective. Percentage 5-year survival for the three most common tumour types is as follows: adenocarcinoma: 49; adenoid cystic carcinoma: 83, and mucoepidermoid carcinoma: 75.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2273.1990.tb00441.xDOI Listing

Publication Analysis

Top Keywords

local recurrence
8
malignant tumours
4
tumours parotid
4
parotid study
4
study patients
4
patients study
4
study presents
4
presents series
4
series malignant
4
malignant parotid
4

Similar Publications

Background: Pancreatic neuroendocrine tumors (PNETs) are uncommon and heterogeneous neoplasms, often exhibiting indolent biological behavior. Their incidence is rising, largely due to the widespread use of high-resolution imaging techniques, particularly influencing the diagnosis of sporadic non-functioning tumors, which account for up to 80% of cases. While surgical resection remains the only curative option, the impact of factors such as tumor grade, size, and type on prognosis and recurrence is still unclear.

View Article and Find Full Text PDF

Omnipolar mapping versus point-by-point mapping approach for catheter ablation of atrioventricular accessory pathway.

J Interv Card Electrophysiol

January 2025

Department of Cardiovascular Medicine, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsugagun, Tochigi, 321-0293, Japan.

Background: The conventional mapping approach for the atrioventricular accessory pathway (AP) involves point-by-point mapping to identify the connection sites of the AP to the atria or ventricle and accurate interpretation of local electrograms. Omnipolar mapping technology (OMT) explains how vector and wave speed are produced by using both unipolar and bipolar signals to obtain omnipolar signals, directions, and conduction velocity. The aim of this study is to verify the effectiveness of OMT for catheter ablation of AP.

View Article and Find Full Text PDF

Purpose: Optimal management of retroperitoneal soft tissue sarcoma (RPS) often requires extensive tumor resections, frequently involving gastrointestinal organs. The impact of these procedures on the nutritional status and hemoglobin (Hb) levels of RPS patients remain unexplored. In this study, we aimed to evaluate preoperative nutritional status as well as the prevalence of anemia in RPS patients, and to investigate longitudinal changes throughout the disease course in order to identify potential strategies for prehabilitation.

View Article and Find Full Text PDF

Background: Atypical teratoid/rhabdoid tumours (ATRTs) are malignant central nervous system tumours, typically presenting in the posterior fossa of very young children. Prognosis remains poor despite current therapy, while tumorigenesis implicates both genomic and epigenetic dysregulation. Primary diffuse leptomeningeal (PDL) ATRT, characterised by the absence of an intraparenchymal mass lesion, is seldom reported but appears associated with a dismal outcome.

View Article and Find Full Text PDF

[CAR-T therapy in elderly patients with relapsed/refractory diffuse large B-cell lymphoma. Clinical case of the San Martino Hospital in Genoa.].

Recenti Prog Med

January 2025

Divisione di Ematologia e terapie cellulari, Irccs Ospedale Policlinico San Martino, Genova.

CAR-T therapy (chimeric antigen receptor T-cell) has revolutionized the prognosis of patients with diffuse large B-cell lymphoma (DLBCL) that have relapsed or are refractory to conventional chemotherapies. In particular, patients who have relapsed or are refractory to two lines of therapy are patients who have a poor prognosis. The advent of CAR-T immunotherapy is an innovative approach with which we can give hope of recovery even in the case of refractory disease, even for patients who are not candidates for high-dose therapies, for example due to age.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!